ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
11.00
+0.07 (0.64%)
Jul 24, 2026, 1:19 PM EDT - Market open
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $99.51 million as of July 24, 2026. Its market cap has increased by 58.44% in one year.
Market Cap
99.51M
Enterprise Value
104.85M
1-Year Change
58.44%
Ranking
Category
Stock Price
$11.00
ChartMarket Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $99.51M, an increase of 4,895.72%. That is a compound annual growth rate of 12.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 99.51M | 78.88% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Black Diamond Therapeutics | 105.44M |
| Entera Bio | 104.99M |
| Coya Therapeutics | 102.74M |
| Oncolytics Biotech | 101.25M |
| Polaryx Therapeutics | 99.89M |
| Pelthos Therapeutics | 98.71M |
| NeOnc Technologies Holdings | 94.14M |
| Aldeyra Therapeutics | 93.50M |